NCT06414863

Brief Summary

The aim of this study is to evaluate the effectiveness of Invisalign Palatal Expander system ingrowing patients. This study compares the treatment outcomes of Invisalign Palatal Expander system to conventional treatments through randomized controlled trial.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
98mo left

Started May 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
May 2024May 2034

First Submitted

Initial submission to the registry

May 8, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

May 10, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 16, 2024

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2028

Expected
6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2034

Last Updated

May 16, 2024

Status Verified

May 1, 2024

Enrollment Period

4 years

First QC Date

May 8, 2024

Last Update Submit

May 13, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Width change

    Transverse changes on CBCTs

    12-18 months

  • Arch width change

    Arch width change measured on digital study casts

    12-18 months

Secondary Outcomes (1)

  • Cephalometric changes

    12-18 months

Study Arms (2)

Invisalign® Palatal Expander System

EXPERIMENTAL

Invisalign® Palatal Expander System will be delivered.

Device: IPE

Hyrax-type maxillary expander

ACTIVE COMPARATOR

Hyrax-type maxillary expander will be delivered. The Hyrax-type maxillary expander will include a midline self-locking screw, which is connected to the conventional molar bands or printed clasps, which are cemented on the maxillary first molars (or on the maxillary primary second molars), via 0.9 mm stainless-steel wire. The framework is soldered to the bands and extends on the palatal side to the primary canines or canines. The expander will be fabricated by a qualified laboratory technician

Device: HE

Interventions

IPEDEVICE

Invisalign palatal expander system: The Invisalign® Palatal Expander System (AlignTechnology, inc.) is 3D-printed orthodontic device for maxillary expansion.

Invisalign® Palatal Expander System
HEDEVICE

Hyrax expander: The Hyrax-type maxillary expander will include a midline self-locking screw. The expansion screw is connected to the conventional molar bands or printed clasps, which are cemented on the maxillary first molars (or on the maxillary primary second molars), via 0.9 mm stainless-steel wire. The framework is soldered to the bands and extends on the palatal side to the primary canines or canines. The expander will be fabricated by a qualified laboratory technician

Hyrax-type maxillary expander

Eligibility Criteria

Age6 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Mixed dentition phase with at least three nonmobile (stable) teeth which have more than 1/4 of primary molar root length left16 in either side
  • Early permanent dentition stage and early permanent dentition but second permanent molars not yet fully erupted in the arch
  • Unilateral or bilateral posterior cross bite patients; or Patients who have been diagnosed with transverse maxillary deficiency (Skeletal transverse discrepancy measured from the estimated center of resistances of the first molars17 ≤ - 3 mm);
  • Patients with Class I or Class II skeletal relationship
  • Subjects willing to consent to the trial

You may not qualify if:

  • Any general medical health problems which may influence treatment
  • Any craniofacial anomalies
  • Skeletal Class III patients
  • Mixed dentition patients with more than 2 heavily restored primary second or permanent first molars.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of the Pacific

San Francisco, California, 94103, United States

RECRUITING

Study Officials

  • Heeyeon Suh

    University of the Pacific

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

May 8, 2024

First Posted

May 16, 2024

Study Start

May 10, 2024

Primary Completion (Estimated)

May 10, 2028

Study Completion (Estimated)

May 10, 2034

Last Updated

May 16, 2024

Record last verified: 2024-05

Locations